Carcinoid

Czech version

Authors: V. Cempírková; P. Havránek
Authors‘ workplace: Interní oddělení Nemocnice České Budějovice, prim. MUDr. Pavel Havránek
Published in: Vnitř Lék 2005; 51(9): 1011-1018
Category: Case Report

Overview

The authors are reporting on two cases of carcinoid tumours, which represent very well the great extent of problems with these malignomas and are discussing diagnostic signs and some puzzles. The first case is an unusual one, with the thrombosis of lienal and portal vein, displaying the difficult and tedious investigation of both etiology and character of the growth. The second case represents the carcinoid syndrom as the cardiologist’s primarily problem. The authors are discussing the possibilities of the treatment in the case of generalised disease.

Key words:
carcinoid - ovarian tumor - delayed diagnosis - heart disease

Sources

1. Schettler G et al. Repetitorium praktického lékaře. Praha: Galén 1995: 815-816.

2. Kiňová S, Ďuriš I, Kratochvílová E et al. Carcinoid tumors - somatostatine in diagnosis and therapy. Bratisl Lek Listy 2002; 103: 108-112.

3. Chatterjee K, Heather JC. Carcinoid heart disease from primary ovarian carcinoid tumorous. A case report a review of literature. Am J Med 1968; 45: 643-681.

4. Modlin IM, Lye KD, Kidd M. Decade Analysis of 13,715 Carcinoid Tumors. Cancer 2003; 97: 934-959.

5. Davis KP, Hartmann LK, Keeney GL et al. Primary ovarian carcinoid tumoros. Gynecol Oncol 1996; 61: 259-265.

6. Lamberts SW, Krenning EP, Klijn JG et al. The clinical use of somatostatin analoques in the treatment of cancer. Baillieres Clin Endocrinol Metab 1990; 4: 29-49.

7. Nobin A, Mansson B, Lunderquist A. Evaluation of temporary liver dearterialization and embolization in patients with metastatic carcinoid tumour. Acta Oncol 1989; 28: 419-424.

8. Klener P. Protinádorová chemoterapie. Praha: Galén 1996: 555-556.

9. Lawrence JP, Ashizuka J, Haber B. The effect of somatostatin on 5-hydroxytryptamin release from carcinoid tumor. Surgery 1990; 108: 1131-1135.

10. Crawford MH, Di Marco JP. Cardiology. 1st ed. London: Mosby 2001: 11-12.

11. Ferri F. Practical Guide to the Care of the Medical Patient. 6th ed. St. Louis: Mosby 2004: 345-347.

12. Abeloff MD. Clinical Oncology. 3rd ed. Philadelphia: Elsevier/Churchill Livingstone 2002: 1631-1636.

13. Charlesworth NE, Vincent SB Sr. Pruritic Dermatoses: Overview of Etiology and Therapy. Am J Med 2002; 113: 25S-33S.

14. Bouros D, Hatzakis K, Labrakis H et al. Association of Malignancy With Diaseases Causing Interstitial Pulmonary Changes, Reviews. Chest 2002; 121(4): 1278-1289.

15. Calhoun K, Toth-Fejel S, Cheek J et al. Serum peptid profiles in patients with carcinoid tumors. Am J Surg 2003; 186: 28-31.

16. Cokonis CD, Green JJ, Manders SM. Primary carcinoid tumor of the skin. J Am Acad Dermatol 2004; 51: S74-S76.

17. Bhattacharya R, Rao S, Kowdley KV. Liver involvement in patients with solid tumors of non-hepatic origin. Clin Liver Dis 2002; 6: 1033-1043.

18. Pandharipande PP, Reichard PS, Vallee MF. High gastric output as a perioperative sign of carcinoid syndrom. Anesthesiology 2002; 96: 755-756.

19. Toth-Fejel S, Pommier RF. Relationships among delay of diagnosis, extent of disease, and survival in patients with abdominal carcinoid tumors. Am J Surg 2004; 187: 575-579.

20. Braunwald E. Heart Diasease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia: Saunders 2001: 1692-1694.

21. Kiňová S, Kováčová E, Bulas J et al. Výskyt karcinoidného syndromu u pacientov s karcinoidom. Vnitř Lék 2004; 50(2): 126-133.

22. Collins N, Bellamy G, Hayes P. Intrapericardial carcinoid metastasis. J Am Soc Echocardiogr 2004; 17: 675-676.

23. Ruszniewski P, Ducreux M, Chayvialle JA et al. Treatment of the carcinoid syndrom with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients. Gut 1996; 39: 279-283.

24. Botero M, Fuchs R, Paulus DA et al. Carcinoid heart disease: a case report and literature review. J Clin Anesth 2002; 14: 57-63.

25. Chaowalit N, Connolly HM, Schaff HV et al. Carcinoid heart disease associated with primary ovarian carcinoid tumor. Am J Cardiol 2004; 93: 1314-1315.

26. Šteiner I. Postižení srdce při karcinoidu. Čes Slov Patol 2003; 39: 55-58.

27. Kiňová S, Ďuriš I. Carcinoid tumor. Bratisl Lek Listy 2001; 102: 495-504.

28. Pellikka PA, Tajik AJ, Khandheria BK et al. Carcinoid heart disease: Clinical and echocardiographic spectrum in 74 patients. Circulation 1993; 87: 1188-1196.

29. Larsen PR, Williams RH. Williams Textbook of Endocrinology. 10th ed. Philadelphia: Saunders 2002: 1857-1870.

30. Rodriguez JA, Meyers MO, Jacome TH et al. Intraoperative Detection of a Bronchial Carcinoid with a Radiolabeled Somatostatin Analog. Chest 2002; 121: 985-988.

Labels

Diabetology Endocrinology Internal medicine

Essential hypertension and Arg16Gly polymorphism of β2-adrenergic receptor gene

Relevance of left ventricular contractile reserve evaluated by dobutamine echocardiography in patients with advanced chronic heart failure

The importance of combined rehabilitation programme in patients with chronic ischaemic heart disease

Big endothelin, interleukin 6 and right ventricle function

Treatment of symptomatic intermitent atrial fibrillation with catheter ablation in the left atrium: Immediate and long-term results in 150 patients

Migraeflux in acute treatment of migraine

The effect of removable total contact cast therapy on healing of patients with diabetic foot ulcers, acute Charcot osteoarthropathy and neuropathic fractures.

Disorders of iron metabolism. Part 2

Noncomplicated course of hypertension, paroxysmal atrial fibrillation and essential thrombocytaemia

Lack of Efficacy of Ticlopidine Pre-Treatment in the Reduction of Troponin I Release Following Percutaneous Intervention in Stable Angina Patients

Article was published in

Internal Medicine

2005 Issue 9